Progress will be measured through an annual review of healthcare facilities provided with WASH facilities. Better Life for All Foundation Nigeria The Better Life for All Foundation BLAF , a non-governmental organization in Nigeria, commits to sustaining grassroots education and enlightenment on the use and misuse of antibiotics while promoting awareness on the global public health threats of antibiotic resistance.
Having successfully led several grassroots awareness on the dangers of antibiotics misuse and antimicrobial resistance AMR , BLAF will continue to reach out to adolescents, youths and nursing mothers with sensitization programs to promote infection prevention and control and antibiotics stewardship.
Through community outreach in the coming year, BLAF will advocate for social and behavioral changes that promote antibiotic stewardship and infection prevention and control. BD California, U. BD Becton, Dickinson and Company commits to helping slow the spread of antibiotic resistance by improving awareness, surveillance, infection prevention, and stewardship. BD is mobilizing the Antimicrobial Resistance Fighter Coalition campaign to improve awareness; will support surveillance and research by collating, in specific projects, MedMinedTM data with the CDC to help better understand resistance in the U.
Together with our partners, we will continue to support research and development of vaccines and novel biologics to prevent drug-resistant diseases and protect lives, especially in low- and middle-income countries. We are also committed to investing in research to understand the burden of antimicrobial resistance on vulnerable populations in order to better quantify the impact of vaccines on drug-resistant infections and inform innovative approaches to preventing resistant infections.
The platform will connect small and medium enterprises in Europe that are driven by research and development and focused on AMR with pharmaceutical companies, academia, investors and governmental institutions across the globe.
This will allow small and medium enterprises to discuss their specific challenges in bringing new antimicrobial treatments and diagnostics to the market. This will include global networking with a focus on AMR innovation, financing, and investments between AMR innovators and investors as well as between human and animal health stakeholders.
BIOMIN Austria BIOMIN, an animal nutrition firm that harnesses the power of science to support farm animal health and performance naturally, commits to expanding the reduction of non-medically necessary use of antibiotic feed solutions across the agriculture sector globally. The BIOMIN Research Center undertakes considerable scientific research and development to further enhance the sustainability of the livestock and aquaculture industries and to limit or decrease rates of antibiotic resistance on farms.
BIOMIN will continue to support this initiative through knowledge sharing of scientific findings and industry best practices along with technical consulting for commercial partners. Bio-Rad Laboratories California, U. Bio-Rad Laboratories commits to positively impacting appropriate and targeted use of antibiotic prescriptions by advancing diagnostic technologies that enable rapid identification of bacteria resistant to antibiotics from the current standard of 24 to 48 hours to less than an hour.
Biotia New York, U. Biotia, an artificial intelligence, health tech firm, commits to advancing available technology such as sequencing-based laboratory workflow, software, and databases to help quickly and accurately identify and track antimicrobial resistance in healthcare settings.
Biotia will conduct at least three pilots in hospitals to test viability and implementation of AMR products, as well as collect substantial amounts of DNA sequence data of pathogens and resistant germs.
These data will build a database to inform work in clinical settings and prevent infections. Biotia will also share the results of this work through at least one peer-reviewed manuscript, the press, scientific meetings, and with Biotia hospital customers. BioVersys Switzerland BioVersys AG, a Swiss pharmaceutical company, commits to initiating clinical trials in for their advanced research and development programs for hospital infections and tuberculosis.
BioVersys AG focuses on research and development of small molecules acting on novel resistant bacterial targets and targeted microbiome therapies. Broad-spectrum antibiotics are often used as an alternative to penicillin, driving antibiotic resistance. This assessment will improve antibiotic use in BJC facilities by allowing for the safest and most effective antibiotics to be prescribed.
Boehringer Ingelheim Germany Boehringer Ingelheim, a company focused on advanced disease prevention for animal health, commits to reducing the use of and need for antibiotics in animals through an integrated health management approach using technologies that enable effective monitoring, early detection, and accurate diagnosis of resistant infections in animals. Bolb Incorporated California, U.
Bolb Incorporated is a manufacturer of germicidal Ultraviolet C Light Emitting Diode UVC LED platforms for chemical-free and touch-free disinfection of hospital environments to prevent exposure to infectious pathogens. Bolb commits to performing three hospital user studies during to measure the impact of its novel solutions and report results in infection prevention journals.
The use of UVC in healthcare facilities is regulated by the Environmental Protection Agency and is currently deployed in more than hospitals globally. The wider deployment of new LED capabilities has the potential to protect patients, nurses and workers, improving outcomes, and, as a result, lowering reliance on the use of antibiotics.
Boston Scientific Massachusetts, U. Boston Scientific also commits to providing and expanding their single-use products designed to minimize the risk of infection transmission and improve efficiencies by eliminating the need for reprocessing and tracking.
Bugworks Research, Inc. We will continue to endeavor to beat superbugs via innovation, while making these products accessible and available to humanity. Bugworks will work closely with the government of India and other countries to promote stewardship of these novel antibiotics, so that these drugs stay effective for many years.
C Diff Foundation Florida, U. C Diff Foundation commits to continuing to recognize the serious disease burden and significant economic impact that antimicrobial resistance AMR and healthcare-associated infections place on patients, their families, in communities, and the health care systems throughout the world.
As a part of the AMR Challenge, the C Diff Foundation will continue to acknowledge and share the importance of AMR stewardship programs; develop or expand ongoing campaigns at national or sub-national levels to promote and improve hand hygiene methods and compliance among health care providers; and make reliable and validated information available on antibiotic use and AMR stewardship programs, infection prevention, environment safety, and vaccines, therapeutics and diagnostics at the community and district levels to encourage best-practices.
The California Department of Public Health CDPH commits to addressing the threat of antimicrobial resistance through a coordinated department-wide strategic framework for preventing the emergence and containing the spread of antimicrobial resistance in California. In , the CDPH Healthcare Associated Infections HAI Program and local public health staff recruited the clinical laboratory that serves 12 of 22 California long-term acute care hospitals to conduct enhanced surveillance and confirmation of Candida auris.
The CDPH HAI Program has responded to four high-concern antimicrobial resistance mechanisms detected by six California laboratories recruited to participate in the Antibiotic Resistance Laboratory Network targeted surveillance program. Capital Health New Jersey, U. Capital Health, a two-hospital health system serving 83, covered lives in New Jersey, commits to a collaborative approach to meet challenges posed by antibiotic resistance.
Given the importance of supporting the proper use of these lifesaving drugs when they are needed most, each award agreement will include commitments to access and stewardship of these new antibiotics, vaccines, and diagnostics. CarePortMD, a platform that connects patients with clinicians in Delaware and Pennsylvania, commits to evidence-based prescribing of antibiotics.
CarePortMD will implement a process for educating patients at the time of withholding antibiotics coupled with a protocol for scheduling a brief telemedical follow up assessment within hours. This prescribing process provides patients and prescribers with either reassurance regarding the treatment plan, or an opportunity to modify use if a primary bacterial or emerging superinfection is identified. Catholic Relief Services Maryland, U. From , CRS will direct interventions at more than healthcare facilities.
CRS commits to influence national health and water policies and budgets in each country to replicate the Clean Clinic Model across territories, effectively improving WASH in healthcare facilities across every facility. We believe that together our impact is greater. CDC is committed to providing the evidence base to identify the most effective safe drinking water, sanitation, and hygiene WASH and infection prevention and control IPC interventions in healthcare facilities.
CDC is also committed to providing technical assistance to partners to implement those interventions. CDC strengthens capacity through training and developing global guidance documents used worldwide.
CDC will continue these activities to support partners, help ensure sustainability, and integrate WASH in healthcare facilities into larger health initiatives as resources permit. The Center for Global Safe Drinking Water, Sanitation, and Hygiene WASH at Emory University commits to the application of rigorous scientific methods to address the most pressing WASH research questions in healthcare facilities, such as determining the health outcomes of mothers and neonates who receive care from healthcare facilities that have safe or unsafe WASH conditions.
Emory commits to the continued dissemination of information and maintaining a web-based platform that facilitates connection, the sharing of best practices, and promotion of sustainable interventions among a community of practice of more than individuals from non-governmental organizations, government, engineering, and private corporations.
The Center for Integrated Management of Antimicrobial Resistance CIMAR , a collaboration between Tufts University and Tufts Medical Center, commits to develop combination drug therapies for human and animal medicine that treat infections and slow antimicrobial resistance. CIMAR engages in environmental surveillance in healthcare, soil, and water to control the spread of antimicrobial resistance, using tools from epidemiology, engineering, and the social sciences.
Scientists find levels of resistance all over the country and map them to determine where the sources are located. CIMAR also commits to promoting the responsible use of antibiotics to improve patient treatment outcomes and is developing high school and undergraduate-level educational programs about antibiotic resistance. Cepheid California, U. Rapid and accurate diagnostic tests can help healthcare providers improve antibiotic prescribing decisions. Cepheid commits to develop and market molecular diagnostic products to optimize antimicrobial use in patients; provide diagnostic tests and disease tracking software that facilitates public health surveillance of infectious organisms, allowing for real-time detection of the organisms and drug resistance; collaborate directly with pharmaceutical companies to develop tests that support clinical trials of new antibiotics; and work with academic, industry, and government partners to develop sound public policy regarding the promotion of antimicrobial infection control and antibiotic stewardship programs.
CAPriCORN institutions will improve the tracking of inpatient antibiotic use and resistance by generating measures using a common data model from PCORnet, a national research data network. These measures will be made available to local antibiotic stewardship and infection control programs, and shared across CAPriCORN sites to improve antibiotic use and slow spread of resistant infections.
As a local health department responsible for direct healthcare facility engagement, the Chicago Department of Public Health CDPH commits to continued surveillance and response to antibiotic-resistant infections in healthcare settings. CDPH conducts onsite investigations and advises providers on infection control gap mitigation. CDPH will leverage surveillance data for public health response and train healthcare staff across the care continuum in core antibiotic stewardship principles and appropriate antibiotic use.
CDPH commits to working with state, local, academic, and clinical partners to establish regional standards for infection control and antibiotic stewardship by to reduce emergence and spread of multi-drug resistant bacteria. In collaboration with state and local public health departments, Rush will use regional strategies and work with state and local partners to prevent CRE infections and protect the Chicago metropolitan region of 9.
Christian Health Association of Ghana Ghana Christian Health Organization of Ghana CHAG commits to adopting safe drinking water, sanitation, and hygiene WASH as a vital tool for reigniting primary healthcare as a means of attaining universal health coverage for all in Ghana, including rural and underserved areas. Circle of Life Healthcare Private Limited India Circle of Life Healthcare Private Limited, a healthcare analytics company in India, commits to continue developing antimicrobial stewardship software using artificial intelligence technology to deliver a personalized predicted antibiogram for patients, allowing prescribers to prescribe more accurately while waiting on culture results from laboratory tests.
The software has been deployed in some large tertiary care hospitals in the Indian subcontinent with expansion plans to Singapore and the United States. Along with these partner organizations, CityMD will promote education, adoption, and implementation of toolkits, and tracking of stewardship metrics by measuring and tracking the Healthcare Effectiveness Data and Information Set HEDIS measures for the diagnoses of pharyngitis, bronchitis, and upper respiratory infection.
CityMD is committed to improving antibiotic stewardship across the urgent care industry and promoting the highest level of care for the communities they serve. The ASP was found to be associated with a decrease in antibiotic use. Using this data, CLSI commits to developing AST standard reference methods; providing AST testing quality control parameters; establishing breakpoints and epidemiological cutoff values; and providing information on testing and reporting.
In January , CLSI will publish the 30th edition of M, a publication that will contain current information for drug selection, interpretation, and quality control.
Clinique Naoufel Algeria Clinique Naoufel, a private hospital in Algeria, commits to improve antibiotic use and reduce the spread of resistant infections by implementing best practices recommended by the CDC for antibiotic stewardship and infection prevention and control throughout its facility. Clorox Healthcare California, U.
Clorox Healthcare will also continuously innovate to make effective infection prevention products, and support front-line healthcare and environmental services professionals with evidenced-based protocols, education, and training.
Finally, Clorox Healthcare commits to raising awareness of infection prevention and stewardship priorities among healthcare providers and the general public. These companies, employees, and partner organizations commit to advancing knowledge among clinicians, policymakers, and payers of the benefits of using innovative, biomarker-assisted sepsis treatment and antibiotic use to improve critical public health outcomes.
The report will include pathogen-specific information, and act as an educational resource to empower community members and stakeholders to better understand and respond to resistance threats in Colorado.
CDPHE will continue to monitor antibiotic-resistant pathogens through surveillance, and update the report in 3 years. Conduent New Jersey, U. Conduent will provide an IT solution that facilitates infection surveillance and antibiotic use data sharing. The Midas Cloud collects and analyzes vaccine, diagnostic, and therapeutic data that can help track antimicrobial resistance AMR trends, drive decisions, and accelerate progress against AMR.
Conduent is committed to making rapid software enhancements to the Midas Cloud, which can accept data from a number of systems, as AMR threats and priorities emerge. CT DPH also commits to supporting antibiotic stewardship activities across the state using updated educational materials on antibiotic resistance and appropriate antibiotic use.
CT DPH is also a CDC Emerging Infections Program site with special projects in the areas of methicillin-resistant Staphylococcus aureus , carbapenem-resistant organisms, and multidrug-resistant foodborne disease attribution. ContraFect Corporation, a developer of biologic therapies, commits to developing new treatment options for life-threatening, antibiotic-resistant infectious diseases using direct lytic agents DLAs from its lysin and amurin product platforms.
Lysins are a new therapeutic class of proteins that kills bacteria, eliminates biofilms, and positively interacts with conventional antibiotics. Amurins are a new class of antimicrobial peptides which exhibit broad-spectrum activity against a wide range of antibiotic-resistant Gram-negative pathogens, including Pseudomonas aeruginosa , Acinetobacter baumannii , and Enterobacter species.
These new therapeutic modalities could provide meaningful improvements to clinical outcomes for patients with antibiotic-resistant infections. ConvenientMD Urgent Care commits to educating its providers and patients on the importance of antimicrobial stewardship, in conjunction with providing high quality, evidence based medical care to our communities. ConvenientMD is now working on a study aimed at decreasing the use of unnecessary antibiotics in patients who present with acute viral pharyngitis.
ConvenientMD anticipates improving provider satisfaction by supplying evidence-based guidelines and patient education materials. CORHA commits to publishing and promoting thresholds, outbreak definitions, and investigation tools for pathogens such as carbapenem-resistant Enterobacterales and Candida auris.
By June , MinuteClinic will advance efforts to educate patients about the appropriate use of antibiotics, and will support providers by providing the tools necessary to be antimicrobial stewardship leaders. DC Health will consult with the Healthcare-Associated Infections Advisory Committee to create reporting methods to ensure usability and sustainability. DC Health will continue using local antibiotic resistance data to alert individual healthcare facilities of emerging threats to take appropriate actions to prevent spread.
Delaware Division of Public Health commits to a coordinated statewide approach promoting the appropriate use of antibiotics, improving patient outcomes, and decreasing the spread of multidrug-resistant pathogens.
The Choosing Wisely statewide antibiotic stewardship initiative reiterates that not all infections warrant antibiotics and seeks to ensure that right antibiotics are given for the right clinical conditions, at the appropriate doses and durations. Tactics include the reduction of inappropriate antibiotics for viral upper respiratory infections in the outpatient setting through provider education and of the use of empiric antibiotics beyond 72 hours in hospitalized patients suspected of having an infection.
Desert Research Institute DRI and Transform International TI are organizations investigating the effects of natural and human-induced environmental change and building local capacity in developing countries. The organizations commit to developing frameworks for long-term sustainability of safe drinking water, sanitation, and hygiene WASH services in healthcare facilities throughout the developing world by focusing on strengthening local capacity, training, monitoring, evaluation, resolution, and learning.
DRI and TI aim to develop, test, and share guidelines that facility staff and local governments can use, providing a system of ongoing operation and maintenance of WASH services. Development Associates LLC—a global health consulting company—commits to monitoring and tracking antimicrobial resistance AMR in Latin America and the Caribbean to provide information for medical research developments and reduce the burden of disease on communities.
Development Associates will use existing data from peer review journals and research studies and conduct focus groups to develop community interventions to track and monitor AMR. Doctor on Demand California, U. Across its hundreds of providers, Doctor on Demand will lower unnecessary antibiotic prescribing by 20 percent by December for acute upper respiratory infections including bronchitis, sinusitis and pharyngitis and require two hours of continuing education training for all providers.
Duke University and the Duke Center for Antimicrobial Stewardship and Infection Prevention commits to working with colleagues in 20 hospitals throughout the southeastern U. E-Clinic Mongolia E-Clinic—an integrated healthcare platform company with more than healthcare organizations in Mongolia—commits to developing antimicrobial stewardship software to facilitate more accurate prescriptions by clinicians.
E-Clinic also commits to sharing data and best practices with local health providers to improve use of antibiotics and infection prevention and control. Ecolab, Inc. Minnesota, U.
Ecolab provides water, hygiene, and energy technologies and services at nearly 3 million locations in more than countries. ECRI Institute is an independent non-profit organization that advances effective, evidence-based health care.
In , ECRI commits to conducting hands-on evaluation and testing of infection reduction technologies, such as hand hygiene monitoring systems, ultraviolet disinfection systems, and disinfection caps.
ECRI will also analyze reports of adverse events and near misses shared by healthcare delivery organizations, develop strategies for reducing harm, vet the trustworthiness of guidelines, and disseminate guidance and alerts that prioritize patient safety and strategies for infection control and prevention.
EPN will raise awareness about the problem of antibiotic resistance; promote infection prevention programs including safe drinking water, sanitation, and hygiene WASH ; promote antibiotic stewardship programs; and work to increase access to quality-assured antibiotics. Elanco Indiana, U. Elanco, an animal health company dedicated to developing innovative solutions that protect and enhance animal health, commits to investing at least 50 percent of their food animal research and development budget in projects that will lead to alternatives for medically important antibiotics, including introduction of non-medically important antibiotics to replace colistin use in key emerging markets; engaging in two partnerships to increase access to veterinary and professional oversight in countries with limited resources; improving responsible antibiotic use by expanding data collection and analytics of animal husbandry and health outcomes to inform best practices; and by encouraging implementation of vaccination and nutrition programs to prevent disease.
Elemeno Health California, U. Elemeno Health, a cloud-based solution for engaging front-line healthcare teams, commits to continued promotion of antibiotic stewardship and the prevention of healthcare-associated infections through microlearning tools such as interactive guides, smart checklists, and concise how-to videos. These tools currently are accessible and actionable in 11 healthcare organizations in the U. The Emory Antibiotic Resistance Center ARC commits to hosting interdisciplinary brainstorming and networking sessions to discuss cutting edge research findings and collaborative research opportunities in conjunction with ARC seminars given by invited external experts three times each year.
These sessions will feature a seminar presented by a national expert on antibiotic resistance. Participants across the leading research institutions in Georgia, including Georgia Institute of Technology, University of Georgia, Morehouse School of Medicine, and Emory University will share research findings and promote the use of shared infrastructure and collaborations across institutions.
By , ENABLE commits to increasing the pipeline of medicines against Gram-negative infections including: three antibacterial lead compounds, two antibacterial development candidate medications, and at least one compound for preclinical and Phase 1 clinical studies. Engineering Ministries International Colorado, U. Engineering Ministries International EMI , a Christian non-profit development organization of architects, engineers, surveyors, and construction managers, commits to being a technical resource for the design and implementation of appropriate and sustainable safe drinking water, sanitation, and hygiene WASH solutions in the healthcare facilities and communities where they work.
With offices in 10 countries and projects in more than 90 countries, EMI works within the local context to design and construct culturally-appropriate facilities that are sustainable, affordable, and transformational. ECDC launched an online resources directory to support EU member states and institutions in developing guidelines for the prevention and control of antimicrobial resistance and healthcare-associated infections.
Since , ECDC also coordinates European Antibiotic Awareness Day, raising awareness about the need for prudent use of antibiotics and will hold one on November 18, Evolve Biosystems, Inc.
Evolve Biosystems commits to providing infant focused microbiome-based solutions to aid in the fight against antimicrobial resistance, including diagnostic tools, under the Evivo brand. Evolve is currently preparing for a clinical study to start late to test a point of care device that screens infant stool for abundance of potential pathogens known to harbor resistance genes.
Evolve is building a database with collaborators aimed at creating and disseminating a deeper, more robust understanding of the infant gut metagenome, how it differs from adults, how exposure and diet shape this community, and the abundance of antimicrobial resistance within infants and children globally in different healthcare settings.
Express Scripts Missouri, U. Express Scripts is the largest independent manager of pharmacy benefits in the U.
Serving more than 85 million people, Express Scripts commits to leverage prescription drug administrative claims for insights on clinicians prescribing pattern. This commitment will enable FAIRR to drive changes in corporate practice to reduce and ultimately phase out the routine use of antibiotics to protect public health and optimize their long-term value. Company progress will be assessed on an annual basis.
Recognizing that increasing WASH in healthcare is vital to combating antimicrobial resistance, Faiths for Safe Water FSW , an advocacy project prioritizing funding for the global water crisis, offers pro bono media consulting to multi-faith leaders and faith-based organizations making a commitment to safe drinking water, sanitation, and hygiene WASH in healthcare facilities.
FSW will assist in strategically editing and placing content such as blogs, op-eds, and select video through cultivated, targeted media opportunities. FSW will perform content editing and ongoing placement. Government of Finland Finland The Finland Ministry of Social Affairs and Health, National Institute for Health and Welfare THL , Ministry of Agriculture and Forestry MMM , and Finnish Food Safety Authority Evira commit to developing a real-time notification and reporting system to detect unusual events, including extremely antimicrobial-resistant bacteria, at local, regional, or national level to support outbreak investigations and infection control measures; improving surveillance of human antimicrobial consumption; constructing a system to collect use data on all animal species; and establishing an expert group on antimicrobial resistance AMR and antimicrobial consumption in each hospital that follows and controls AMR infections and steers the use of antimicrobials.
First Arabian Drug Information Center Saudi Arabia The First Arabian Drug Information Center FADIC , a professional health care organization in the Middle East, commits to maintaining the appropriate use of antibiotics through antimicrobial stewardship education and by providing certification in antimicrobial stewardship training programs for pharmacists, physicians, nurses, and other healthcare professionals.
FADIC will also provide a roadmap for applying antimicrobial stewardship in multiple healthcare settings, including acute-care hospitals, long-term care facilities, ambulatory care settings, and community pharmacies to provide an evidence-based practice. First Light Diagnostics Massachusetts, U. First Light Diagnostics, Inc. First Light Diagnostics will manage the testing and reporting processes using a user-friendly interface or have the option to integrate with a hospital laboratory information system to provide clinicians with diagnostic testing results.
The platform will help eliminate the unnecessary use and overuse of antibiotics that contribute to the rise of antibiotic-resistant pathogens by providing the care team with information to inform diagnosis.
Florida Department of Health Florida, U. The Florida Department of Health Florida Health commits to promoting evidence-based strategies for reducing the spread of antibiotic-resistant organisms, improving prescribing practices with data sharing among health care personnel, and containing outbreaks of novel organisms. Florida Health will continue working with health care facilities to offer educational sessions, on-site assessments, and outbreak assistance.
Florida Health will also develop and provide health care facilities with antimicrobial stewardship toolkits, a standardized process for conducting infection control assessments, and a tracking system for outbreak responses. Foundation for Innovative New Diagnostics Switzerland The Foundation for Innovative New Diagnostics FIND , working on the development and delivery of diagnostics to address global health priorities, commits to developing new tests by to definitively diagnose gonorrhea prior to treating patients with antibiotics.
FIND commits to developing one or more targeted sequencing solutions for the diagnosis of drug-resistant tuberculosis. FIND is also creating digital solutions to link antimicrobial resistance AMR data from local sources, such as clinics and laboratories, to national-level surveillance systems.
Its AMR Diagnostics Use Accelerator evaluates a package of diagnostic, clinical algorithms, and behavior change interventions. Foundation for Neglected Disease Research India Foundation for Neglected Disease Research FNDR , a research organization based in India, commits to delivering novel drug candidates for various neglected diseases and developing inexpensive, quick, and accurate diagnostic methods.
FNDR currently has two drug candidates for drug-resistant tuberculosis TB , one which is partnered with the TB Alliance, and the other is a proprietary molecule in a late stage preclinical development that could be released in the next years.
This One Health focused action plan includes 40 actions across five objectives: raising awareness among the public and healthcare professionals; antibiotic stewardship and infection prevention and control; research and innovation; monitoring and surveillance and governance; and intersectoral policy.
The plan coordinates ministries, agencies, and research organizations at a national level. France will continue to make strides in these areas and will measure progress using a set of indicators.
Gelest, Inc. Pennsylvania, U. The products will include antimicrobial laundry additives, antimicrobial surface cleaning wipes, and antimicrobial wound care dressings, and will launch in Genesis Healthcare, Inc. These precautions require healthcare facility personnel to wear a gown and gloves during high-contact, resident care activities to assist in reducing the spread of targeted MDROs. Success will be measured through adherence to precautions and reduced numbers of targeted MDROs in healthcare acquired infections, hospitalizations and antibiotic use.
The results will be shared publicly through communication with other long-term care providers and professional organizations. Global Antibiotic Research and Development Partnership Switzerland The Global Antibiotic Research and Development Partnership GARDP , a non-profit public health innovator, commits to delivering five new antibiotic treatments by in response to the growing burden of antibiotic-resistant infections. These treatments focus on the priority pathogens identified by the World Health Organization, current unmet needs for diseases and key populations—including treatments for serious bacterial infections in adults and children, newborns with sepsis, and for sexually-transmitted infections.
GARDP believes all infections should be treatable and aims to make the treatments it develops affordable and accessible to people who need them, wherever they are in the world. Global Handwashing Partnership Washington, D. Global Handwashing Partnership GHP , a coalition of partners that promote handwashing at local, national and international levels, commits to advocating for improvements in safe drinking water, sanitation, and hygiene WASH , particularly hand hygiene in healthcare settings globally.
GHP will reach out to private entities, academic institutions, multilateral and government agencies, and non-governmental and community-based organizations to encourage action on hand hygiene; profile global success stories; compile and disseminate key evidence; and equip advocates with tools and data to impact handwashing among target populations. GHP will also coordinate hand hygiene advocacy efforts to help members across sectors become hand hygiene advocates. Global Health Alliance Melbourne Australia Trends project that by , Asia will have the highest number of deaths attributable to antimicrobial resistance AMR on earth.
Through 36 member organizations across nine sectoral types, the Global Health Alliance Melbourne GLHAM commits to a collective and coordinated multidisciplinary approach to addressing AMR at a national and regional level.
GLHAM will take joint action through its AMR community of practice to strengthen regional health security through diagnosis and measurement; preventing transmission of existing resistant strains; and preventing emergence of new resistant strains. Global Health Council Washington, D. Step 1. Step 2. Choose the output format as MP3 from the drop-down list, you can find the MP3 format in audio documents. Step 3. Enter the email address for the output MP3 files, which you will receive the audio formats later after conversion.
If you have massive files that need to convert, you are only allowed to convert 2 AMR files at the same time. When you get into the official website of Online Convert, you can choose Audio Format and select "Convert to MP3" as the target format.
Adjust the settings for the MP3 format, such as the audio bitrate, sampling rate, audio channels, and more others. Step 4. By clicking the "Convert file" button to convert AMR to MP3 after you confirm the agreements for the online converter. It allows you to edit existed video and audio files by cutting length, rotating and ripping. And after editing, you can watch and listen to the new file. Also, as an AMR audio converter, it supports converting multiple audio formats in high quality.
Convert to AMR amr Adaptive Multi Rate This format was originally intended for voice compression and is able to change the bit rates of encoded audio data. AMR is actively used for encoding and decoding voice while its being transmitted over network channels. The format allows one to consider network capacity and adapt it to channel loads.
Due to this, the voice quality is practically undiminished. Almost any player on any platform can open mp3 files.
0コメント